Indications, complications and withdrawals of inferior vena cava filters in a Colombian hospital
DOI:
https://doi.org/10.17533/udea.iatreia.171Keywords:
Equipment and Supplies, Pulmonary Embolism, Vascular Surgical Procedures, Venous ThrombosisAbstract
Introduction: Inferior vena cava filters are endovascular devices utilized in clinical practice to mitigate the risk of acute venous thromboembolic disease progression to pulmonary embolism in cases of absolute contraindications to anticoagulation. Currently, there are no reports on the experience of using such devices in Colombia.
Objective: To assess the indications, practices, retrieval rates, and complications of inferior vena cava filters in a university hospital in Colombia. Methods: A retrospective study was conducted at a tertiary-level university hospital in Colombia. Patients who had undergone inferior vena cava filter implantation were included, with exclusion of those with essential data missing for analysis. Descriptive statistics and Student’s t-test were performed for group comparisons.
Results: A total of 196 patients with acute venous thromboembolic disease who had undergone inferior vena cava filter implantation were included. None of the patients received the device as primary prophylaxis. Filter-related complications occurred in 13 patients, and retrieval was considered for 118 patients, of whom 108 retrievals were successful. Among the included oncology patients who received an inferior vena cava filter, 36 underwent retrieval attempts, achieving success in 32 cases (88.8%).
Conclusions: This study revealed that the most common indications for inferior vena cava filter implantation were the need for surgery, acute bleeding or bleeding risk, and catheter-guided local thrombolysis. The most frequent complication was acute inferior vena cava thrombosis and filter tilting. Inferior vena cava filter retrieval was successful in the majority of attempted
cases.
Downloads
References
(1) Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schuünemann HJ; American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel. Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb;141(2 Suppl):7S-47S. https://doi.org/10.1378/chest.1412S3
(2) Decousus H, Leizorovicz A, Parent F, Page Y, Tardy B, Girard P, et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med. 1998 Feb 12;338(7):409-15. https://doi.org/10.1056/NEJM199802123380701
(3) US Food and Drug Administration. Removing retrievable inferior vena cava filters: initial communication [internet]. Maryland: US Food and Drug Administration; 2010. [Citado 2022 mar 24]. Disponible en: https://acortar.link/RLMru3
(4) Weinberg I, Kaufman J, Jaff MR. Inferior vena cava filters. JACC Cardiovasc Interv. 2013 Jun;6(6):539-47. https://doi.org/10.1016/j.jcin.2013.03.006
(5) Rogers FB, Cipolle MD, Velmahos G, Rozycki G, Luchette FA. Practice management guidelines for the prevention of venous thromboembolism in trauma patients: the EAST practice management guidelines work group. J Trauma. 2002 Jul;53(1):142-64. https://doi.org/10.1097/00005373-200207000-00032
(6) Rajasekhar A, Streiff MB. Vena cava filters for management of venous thromboembolism: A clinical review. Blood Rev. 2013;27:225–41. https://doi.org/10.1016/j.blre.2013.07.001
(7) Jiang J, Tu J, Jia Z, Chen J, Cao H, Meng Q, et al. Incidence and Outcomes of Inferior Vena Cava Filter Thrombus during Catheter-directed Thrombolysis for Proximal Deep Venous Thrombosis. Ann Vasc Surg. 2017;38:305–9. https://doi.org/10.1016/j.avsg.2016.05.108
(8) Kolbel T, Alhadad A, Acosta S, Lindh M, Ivancev K, Gottsater A. Thrombus embolization into IVC filters during catheter-directed thrombolysis for proximal deep venous thrombosis. J Endovasc Ther. 2008;15:605–13. https://doi.org/10.1583/08-2462.1
(9) Kwon SH, Park SH, Oh JH, Song MG, Seo T-S. Prophylactic Placement of an Inferior Vena Cava Filter During Aspiration Thrombectomy for Acute Deep Venous Thrombosis of the Lower Extremity. Vasc Endovascular Surg. 2016;50(4):270–6. https://doi.org/10.1177/1538574416644524
(10) Lee S-H, Kim H-K, Hwang J-K, Kim S-D, Park SC, Kim J-I, et al. Efficacy of Retrievable Inferior Vena Cava Filter Placement in the Prevention of Pulmonary Embolism during Catheter-Directed Thrombectomy for Proximal Lower-Extremity Deep Vein Thrombosis. Ann Vasc Surg. 2016;33:181–6. https://doi.org/10.1016/j.avsg.2015.10.034
(11) Mewissen MW, Seabrook GR, Meissner MH, Cynamon J, Labropoulos N, Haughton SH. Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry. Radiology. 1999;211:39–49. https://doi.org/10.1148/radiology.211.1.r99ap4739
(12) Protack CD, Bakken AM, Patel N, Saad WE, Waldman DL, Davies MG. Long-term outcomes of catheter directed thrombolysis for lower extremity deep venous thrombosis without prophylactic inferior vena cava filter placement. J Vasc Surg. 2007;45:992–7. https://doi.org/10.1016/j.jvs.2007.01.012
(13) Karmy-Jones R, Jurkovich GJ, Velmahos GC, Burdick T, Spaniolas K, Todd SR, et al. Practice Patterns and Outcomes of Retrievable Vena Cava Filters in Trauma Patients: An AAST Multicenter Study. J Trauma Acute Care Surg. 2007;62(1):17–25. https://doi.org/10.1097/TA.0b013e31802dd72a
(14) Mismetti P, Laporte S, Pellerin O, Ennezat P-V, Couturaud F, Elias A, et al. Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial. JAMA. 2015;313:1627–35. https://doi.org/10.1001/jama.2015.3780
(15) Goodin A, Han Q, Raissi D, Brown JD. A Review of Interventions to Increase Vena Cava Filter Retrieval Rates. Ann Vasc Surg. 2018;51:284–97. https://doi.org/10.1016/j.avsg.2018.02.010
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Iatreia
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Papers published in the journal are available for use under the Creative Commons license, specifically Attribution-NonCommercial-ShareAlike 4.0 International.
The papers must be unpublished and sent exclusively to the Journal Iatreia; the author uploading the contribution is required to submit two fully completed formats: article submission and authorship responsibility.
